Urinary growth hormone (uGH) excretion and serum growth hormone concentrations have been compared in three groups of children.
1 and 2 each had a 24 hour serum growth hormone profile (sampling every 20 minutes) and concurrent urine collection. The 12 boys in group 3 had a total of 21 profiles (sampling every 15 minutes for 12 hours) and concurrent urine collections.
In the prepubertal children (n=17), in both groups 1 and 2, there was a significant correlation between mean serum growth hormone and total uGHng/g creatinine. There were also significant correlations between total uGHng/g creatinine and both peak serum growth hormone and mean amplitude of the pulses in the growth hormone profile. In the pubertal children (n=22), in groups 1 and 2, whether combined or in separate groups, there was no significant correlation between total uGHng/g creatinine and mean serum growth hormone, peak serum growth hormone, or mean amplitude of the pulses in the growth hormone profile. In group 3 there were significant correlations between total uGHng/g creatinine and both the mean serum growth hormone and mean amplitude of the pulses in the profile. Therefore uGH estimations appear to correlate well with serum growth hormone profiles in children who are prepubertal or in early puberty, but not in those further advanced in pubertal development. These results may reflect a variation in the renal handling of growth hormone during pubertal development. uGH estimation may be an unreliable screening investigation for growth honnone insufficiency in mid to late puberty. The All the studies were approved by the local ethical committee and informed consent was obtained from the children and their parents.
ASSAYS
Serum growth hormone profiles were assayed in one batch using a standard diagnostic immunoradiometric assay (IRMA) kit (Netria, St Bartholomew's Hospital, London), and international reference standards. Urine samples were collected in polythene bottles kept at 4°C during the collection. Urine volumes were then measured and aliquots stored at -40°C in 0 -1% bovine serum albumin and 0 1% azide solution until assayed, when aliquots were first dialysed against a phosphate buffer for 24 hours at 4°C. Growth hormone concentration was measured by a two step IRMA using 1-5 ml of dialysed urine. The first step consisted of a 24 hour incubation with 100 ,ul of 125 I labelled mouse monoclonal antihuman growth hormone antibody, and the second a 24 hour incubation with 100 [d of sheep polyclonal antigrowth hormone 13 Results There were no significant differences in mean peak and total concentrations of serum growth hormone within group 2, that is between the normal siblings and those under investigation for genetic short stature. In group 1, there was no significant difference in time since cranial irradiation between the prepubertal and pubertal children (6 6 (1-8) v 6 5 (1-7) years) but there was a significant difference in age at cranial irradiation between the prepubertal and pubertal children creatinine in the prepubertal children (r=0-82; p<0001). The relationship was described by the regression equation y=148+0 15x (fig 1) . The correlation-between these two parameters was also significant in groups 1 and 2 taken separately (r=0-88, p=0 009; r=084, p=0O003 respectively), and there was no significant difference in the regression equations between the two groups. There were also significant correlations in the prepubertal children between total uGHng/g creatinine and both peak growth hormone in the growth hormone profile (r=0-86, p<0-001) and mean pulse amplitude in the growth hormone profile (r=0-71, p=0-002). There were significant correlations between total uGHng/g creatinine and both mean serum growth hormone (r=0-74, p<0 001) and mean amplitude of the growth hormone pulses in the 12 hour profile (r=0-4, p=005) in these boys. There was, however, no significant correlation between the total uGH excreted and the peak growth hormone in the profile (r=0-4, p=0 12).
RELATIONSHIP BETWEEN SERUM GROWTH HORMONE PROFILES AND uGH EXCRETION IN
PUBERTAL CHILDREN (FIG 2) The relationship between mean serum growth hormone and total uGHng/g creatinine was not significant in the pubertal children (r= -0-26, p=024) as seen in fig 2. The regression equation (y=4-84-0'03x) was significantly different to that of the prepubertal group (p<0 001) but not significantly different from zero. The correlation between these two parameters was also not significant in either group 1 or 2 taken separately (r=-0-02, p=10; r=-0-4, p=0-22 respectively). Nor was there a significant correlation between these parameters in the boys and girls taken separately (r=0-2, p=0-60; r=-0-6, p=0i1 respectively). In addition, there were no significant correlations in the pubertal group between total uGHng/g creatinine and either peak growth hormone in the growth hormone profile (r=-0-29, p=02) or mean amplitude of the growth hormone pulses in the growth hormone profile (r=-0-34, p=0-2). Expressing uGH excretion as a uGH/g creatinine ratio or as total uGH (pg) did not alter these results. The six pubertal boys in groups 1 and 2 with testicular volumes less than 12 ml (that is, at a similar pubertal stage to the boys in group 3) did, however, show a significant correlation between total uGHng/g creatinine and both mean serum growth hormone and mean amplitude of the growth hormone pulses (r=0 74, p=009; r=0-72, p=001 respectively) when analysed separately.
RENAL FUNCTION
All the children studied had normal plasma urea and creatinine concentrations. In particular the group with ALL had normal renal function after their chemotherapy. Factors Group 1 (ALL) would have been at particular risk of incurring renal damage either as a result of their original disease or in the course of its treatment. Although there is no evidence of overt renal problems in the ALL children studied, they could have incurred sufficient tubular damage during treatment to affect renal handling of growth hormone. The fact that the prepubertal children with ALL were not significantly different from the normal prepubertal children in their excretion of uGH, however, argues against significant tubular damage affecting uGH excretion in these children. There was no difference in treatment, clinical course, or time elapsed since treatment between the prepubertal and pubertal irradiated children, although the children who were pubertal at the time of study were significantly older when originally treated than the prepubertal children (7 3 (3-1) v 3-8 (2 1) years, p<0 05). If anything this should render them less vulnerable, as young children are more susceptible to permanent kidney damage from insults such as urinary tract infections. These observations counter the suggestion that tubular damage in group 1 disrupted uGH excretion. Furthermore the absence of a relationship between uGH excretion and serum concentrations in the normal pubertal group cannot be explained by renal pathology.
In conclusion, further investigation of the impact of both physiological and pathological changes in renal function on uGH excretion are necessary to determine the reliability of uGH as a screening test for growth hormone deficiency. Estimation of uGH does not appear to reflect serum growth hormone concentrations reliably in mid to late puberty and thus is not an appropriate screening test for growth hormone deficiency during puberty. Careful measurement of growth and the more traditional methods of growth hormone assessment remain essential.
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